The global High-Throughput Screening market size is expected to reach $39.45 Billion by 2028 growing at the CAGR of 11.50% from 2021 to 2028. High-throughput screening (HTS) is a technique for scientific experimentation especially used for drug discovery. Using robotics technology, data processing software, liquid handling devices, and sensitive detectors, high-throughput screening allows the researcher to speedily conduct millions of chemicals, genetic, or pharmacological tests. By this process, the researcher can quickly identify active compounds, antibodies, or genes which modulate an actual biomolecular pathway. The outcomes of the experiments help for developing drug design and for understanding the noninteraction or role of a particular location.
| Parameters | Indicators |
|---|---|
| Market Size (2020) | $39.45 Billion |
| CAGR (2021 to 2028) | 11.50% |
| Market Classificationt | Product & Service, Technology, Application, End User |
| Key Companies Profiled | Thermo Fisher Scientific, Agilent Technologies, Inc., Danaher, PerkinElmer, Inc, Tecan Group Ltd., Axxam S.p. A, Bio-Rad Laboratories Inc, Merck Group KGaA, Hamilton Company, and Corning Incorporated |
| Key Countries/Regions Analyzed | US, Canada, Mexico, UK, Germany, France, Italy, Rest of Europe, China, India, Japan, South Korea, Rest of Asia Pacific, Middle East & Africa, and South America |
| Base Year | 2020 |
| Estimated Year | 2021 |
| Forecast Years | 2022 to 2028 |
Driving Factors
The factors driving the growth of the global High-Throughput Screening Market include increasing demand for drug discovery, growing use of HTS in academia for biomedical research, rise in the advancement of technology, increase demand for quick data processing, and increase in automation in High-Throughput Screening. This factor is anticipated for the market growth of the market.
- Increase demand for drug discovery
High-Throughput Screening is used for drug design and drug development. Using High-Throughput Screening, numerous life-threatening diseases drugs can be developed, which increase the High-Throughput Screening market growth. Â The high-Throughput Screening process helps to conduct a number of the test quickly, which saves the time of researcher for the drug design and drug development. Moreover, a high-throughput screening technique is beneficial to decrease the cost of drug development. This factor drives the High-Throughput Screening Market.
Restraining factors
The factors restraining the growth of the global High-Throughput Screening Market include high capital investments and a lack of skilled professionals. This factor is expected to restrain the market growth of the market.
Key Insight in the report:
The Global High-Throughput Screening Market report covers Executive Summary, Market Dynamics, Trend Analysis, Market Size and Forecast, Competitive Intelligence, Market Positioning, Product Benchmarking, and Opportunity Analysis.
The report covers extensive competitive intelligence which includes the following data points:
- Business Overview
- Business Model
- Financial Data
- Financial – Existing
- Financial – Funding
- Product Segment Analysis and specification
- Recent Development and Company Strategy Analysis
- SWOT Analysis
High-Throughput Screening Market Segmentation
High-Throughput Screening Market
The report covers market sizing and forecasting at the country level as well as at the segment level. High-Throughput Screening Market is analyzed across the below-mentioned different segments:
By Product & Service
- Reagents & Assay Kits
- Instruments
- Consumables & Accessories
- Software
- Services
By Technology
- Cell-based Assays
- 2D Cell Culture
- Perfusion Cell Culture
- Lab-on-a-chip (LOC)
- Ultrahigh-throughput Screening
- Bioinformatics
- Label-free Technology
- 3D Cell Culture
By Application
- Target Identification & Validation
- Primary and Secondary Screening
- Toxicology Assessment
- Others
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic & Government Institutes
- Contract Research Organizations
- Others
Regional analysis
Asia Pacific region dominates the high-throughput screening market. It is projected to grow at the highest CAGR during the forecast period, mainly due to factors such as an increase in a public-private partnership, increase in spending for R&D, and rise in government funding.
The High-Throughput Screening Market is analyzed across the below mentioned region.
- North America
- US
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Rest of Asia Pacific
- Rest of the World
High-Throughput Screening Market Ecosystem Players:
Some of the key ecosystem players in of High-Throughput Screening Market include:
- Thermo Fisher Scientific
- Agilent Technologies, Inc.
- Danaher
- PerkinElmer, Inc
- Tecan Group Ltd.
- Axxam S.p. A
- Bio-Rad Laboratories Inc
- Merck Group KGaA
- Hamilton Company
- Corning Incorporated
REPORT CONTENT BRIEF:
- High-Throughput Screening Market historical market size for the year 2020, and forecast from 2021 to 2028
- High-level analysis of the current and future High-Throughput Screening Market trends and opportunities
- Detailed analysis on current market drivers, restraining factors, and opportunities in the future
- High-Throughput Screening Market  historical market size for the year 2020, and forecast from 2021 to 2028
- Vendor market share analysis at each product level
- High Throughput screening market share with a detailed insight into its product segment, financial strength, and strategies adopted.
- Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
Press Release
The Telemedicine Market Is Estimated To Record a CAGR of Around 29.2% During The Forecast Period
The Population Health Management Market Is Estimated To Record a CAGR of Around 13.1% During The Forecast Period
Medical Tourism Market Is Estimated To Record a CAGR of Around 22.9% During The Forecast Period
The Mobile Health Market Is Estimated To Record a CAGR of Around 10.82% During The Forecast Period
The Negative Pressure Wound Therapy Market Is Estimated To Record a CAGR of Around 6.4% During The Forecast Period
Hard-Surface Flooring Market Is Estimated To Record a CAGR of Around 5.12% During The Forecast Period
The Composite Doors & Windows Market Is Estimated To Record a CAGR of Around 7.7% During The Forecast Period
The Medical Supplies Market Is Estimated To Record a CAGR of Around 3.76% During The Forecast Period
The Cosmetic Surgery Market Is Estimated To Record a CAGR of Around 12.20% During The Forecast Period
Global Wearable Medical Devices Market Is Estimated To Record a CAGR of Around 14.06% During The Forecast Period
